Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest update is out from Grand Pharmaceutical Group Limited ( (HK:0512) ).
Grand Pharmaceutical Group Limited has announced a final cash dividend of HKD 0.26 per share for the financial year ending December 31, 2024. This announcement indicates a stable financial performance and is likely to reassure investors and stakeholders about the company’s consistent returns and market positioning.
More about Grand Pharmaceutical Group Limited
Grand Pharmaceutical Group Limited operates in the pharmaceutical industry, focusing on the development and distribution of healthcare products. The company is involved in producing a range of pharmaceutical products, catering to various healthcare needs in the market.
YTD Price Performance: 10.42%
Average Trading Volume: 3,642,419
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$18.81B
See more insights into 0512 stock on TipRanks’ Stock Analysis page.